The Pharmacy and Therapeutics (P and T) Committee is an advisory board established pursuant to Executive Order D004-07. The committee performs clinical reviews of drug classes and makes recommendations which help the Department develop and manage the Medicaid Preferred Drug List (PDL).
The P and T Committee is required to consider clinical criteria such as drug safety and efficacy when making its recommendations. The committee also considers public comments and testimony related to the drug classes being reviewed or other PDL-related agenda items.
2025 Meeting Schedule and Handouts
Our meeting is held virtually. The meeting link will be posted just prior to the meeting for public attendees. It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.
1:00 p.m. - 5:00 p.m.
The Committee meets once quarterly in January, April, July, and October.
October 7, 2025
To Be Announced
July 8, 2025
To Be Announced
April 8, 2025
January 7, 2025
- Agenda / Minutes
- Preferred Drug List Drug Class Review Announcement
- PDL Announcement of Preferred Products
2024 Meeting Schedule and Handouts
October 8, 2024
- Agenda / Minutes
- Preferred Drug List Drug Class Review Announcement
- PDL Announcement of Preferred Products
July 9, 2024
- Agenda / Minutes
- Preferred Drug List Drug Class Review Announcement
- PDL Announcement of Preferred Products
April 9, 2024
- Agenda / Minutes
- Preferred Drug List Drug Class Review Announcement
- PDL Announcement of Preferred Products
January 9, 2024
- Agenda / Minutes
- Preferred Drug List Drug Class Review Announcement
- PDL Announcement of Preferred Products
Our Members
The P and T Committee consists of 7 physicians, 4 pharmacists and 2 client representatives, who are appointed by the Department's Executive Director. Review the Policies and Procedures Manual for more information on the committee's membership, duties and policies.
January 2024 - December 2025 Term
- Gwen Black, PharmD, BCACP
- Thuy McKitrick, PharmD, BCACP
- Joel Tanaka, MD
- Marisa Sharkey, DO
- Katie Boudreaux, PharmD
- Ann Dominguez, MD
January 2025 - December 2026 Term
- Emily Kosirog, PharmD, BCACP
- Daralyn Morgenson, PharmD, BCPP
- Morgan Alonzo, PharmD
Contact Us/Join Us
Program Administrator
Denver, CO 80203
Openings for New Members
The Department has four open positions for the P and T Committee members.
Open positions for applicants are being accepted for the following positions for the terms beginning January 2025:
- One physician who specializes in the practice of psychiatry (January 2025 - December 2026)
- One physician who specializes in the practice of pediatrics (January 2025 - December 2026)
- One physician of any specialty (January 2025 - December 2026)
- One physician who specializes in disabilities (January 2025 - December 2026)
Duties, membership and other term details can be found in the P and T Committee Policies and Procedures.
If interested in serving or know someone who would be qualified, please submit/have them submit a CV along with a completed Conflict of Interest form to:
Colorado Department of Health Care Policy and Financing
Attn: Greg Miller, PharmD
Fax to 303-866-3590 or email greg.l.miller@state.co.us
A CV is not required for the member representative position. A resume (or similar document) is acceptable.
Presenting Testimony
Interested parties who want to present at the meeting shall give at least 3 business days notice (by 5 p.m. MST), prior to the meeting, to James Kim, Pharmacist Account Executive, by email at james.kim@primetherapeutics.com and carbon copy Greg Miller, PDL Pharmacist, by email at greg.l.miller@state.co.us. Please see the specific deadline for testimony on the meeting agenda.
Please see the P and T Committee Policies and Procedures for both written and verbal comments.
Auxiliary aids and services for individuals with disabilities and language services for individuals whose first language is not English may be provided upon request. Please notify the 504/ADA Coordinator or send an email to hcpf504ada@state.co.us at least one week prior to the meeting to make arrangements.